Injuries, Spinal Cord
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Flowonix MedicalNJ - Hackettstown
1 programPrometra II Programmable Pump - Flowonix MedicalN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Nordic PharmaLevetiracetam
Flowonix MedicalPrometra II Programmable Pump - Flowonix Medical
Ekso BionicsEkso GT Rehabilitation Therapy
Clinical Trials (3)
Total enrollment: 173 patients across 3 trials
Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury
Start: Nov 2005Est. completion: Dec 200836 patients
Phase 4Completed
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
Start: Sep 2020Est. completion: Jun 202392 patients
N/AUnknown
The WISE Trial - Walking Improvement for SCI With Exoskeleton
Start: Sep 2016Est. completion: Sep 201945 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.